Vomiting in docetaxel chemotherapy: which to blame, dose or gene?
The adverse effects (AEs) of docetaxel are major limiting factors of its success in the battle against cancer. AEs can be hematological and non-hematological (nausea, vomiting, diarrhea, rash and mucositis). Eventually, the dose is often reduced or regimen is diverted. Single nucleotide polymorphism...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
Federation of American Societies for Experimental Biology
2014
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/35998/ http://psasir.upm.edu.my/id/eprint/35998/ |